SAVER: sodium valproate for the epigenetic reprogramming of high-risk oral epithelial dysplasia-a phase II randomised control trial study protocol. (2021)

First Author: McCarthy C

Attributed to: MICA: The Newcastle Proximity Laboratory funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1186/s13063-021-05373-8

PubMed Identifier: 34225765

Publication URI: http://europepmc.org/abstract/MED/34225765

Type: Journal Article/Review

Volume: 22

Parent Publication: Trials

Issue: 1

ISSN: 1745-6215